AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition – Meet them this November

Talawar Therapeutics Heads to Nasdaq via SPAC Deal to Bankroll Eczema Asset

10 Clinical Trials to Watch Out for in the latter half of 2026 – Read here

Akero execs reunite to advance long-acting psoriasis pill

Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug

InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test

Sanofi halts development of troubled immune drug in eczema

Advancing Delivery Systems to Improve Patient Experience & Enhance Therapeutic Impact

12:00 pm - Wednesday 4th November 2026

Exploring innovative delivery systems, improving usability, to increase patient adherence
Enhancing drug delivery performance to maximize efficacy and improve outcomes
Differentiating therapies through formulation, strengthening positioning, to gain competitive advantage

Anuj Singhal

Chief Executive Officer

Kalm therapeutics